English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

B.K. Felber1, X. Hu1, A. Valentin2, F. Dayton1, Y. Cai1, M. Rosati2, C. Alicea1, N.Y. Sardesai3, R. Gautam4, M.A. Martin4, J.I. Mullins5, and G.N. Pavlakis2 1Human Retrovirus Pathogenesis Section, 2Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702-1201; 3Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA 19462; 4Laboratory of Molecular Microbiology, NIAID, NIH, Bethesda 20892; 5University of Washington, Seattle, WA 98195

34 Novel conserved element HIV/SIV DNA vaccines maximize breadth and magnitude of immune response